Introducing the new CONSORT extension for stepped-wedge cluster randomised trials.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
18 Jan 2019
Historique:
received: 18 07 2018
accepted: 07 12 2018
entrez: 20 1 2019
pubmed: 20 1 2019
medline: 1 6 2019
Statut: epublish

Résumé

The use of the stepped-wedge cluster randomised trial (SW-CRT) is on the increase, and although there are still relatively few SW-CRTs currently published its use is bound to show an increase in the near future. An extension of the CONSORT reporting guideline for SW-CRTs has recently been developed. By making reporting guidelines for this innovative design available relatively early in its development, it is possible that the methodological conduct and reporting of future SW-CRTs will not be at the same risk of low-quality of reporting as is the case with many other study designs. We provide a brief overview of this reporting guideline and encourage authors to use it appropriately; and for journal editors to endorse its use.

Identifiants

pubmed: 30658677
doi: 10.1186/s13063-018-3116-3
pii: 10.1186/s13063-018-3116-3
pmc: PMC6339370
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Subventions

Organisme : Department of Health
ID : SRF-2017-10-002
Pays : United Kingdom

Références

BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
JAMA. 2012 Dec 26;308(24):2594-604
pubmed: 23268518
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Trials. 2015 Aug 17;16:352
pubmed: 26279154
Stat Med. 2016 Jun 15;35(13):2149-66
pubmed: 26748662
BMJ. 2016 Aug 16;354:i4291
pubmed: 27530617
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Trials. 2017 Jan 21;18(1):33
pubmed: 28109321
Trials. 2017 Dec 21;18(1):610
pubmed: 29268758
J Physiother. 2018 Jan;64(1):63-66
pubmed: 29289591
BMJ. 2018 Nov 9;363:k1614
pubmed: 30413417

Auteurs

Karla Hemming (K)

Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK. k.hemming@bham.ac.uk.

Monica Taljaard (M)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1053 Carling Avenue, Ottawa, ON, K1Y4E9, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

Jeremy Grimshaw (J)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1053 Carling Avenue, Ottawa, ON, K1Y4E9, Canada.
Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH